Delivery Order SPE2DR25D9311-SPE2DR26FSBE8
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $5,114.52 to DMS Pharmaceutical Group Inc. for the supply of Boostrix TDAP vaccine in 0.5mL syringes. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this contract at its facility in Park Ridge. The delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and no set-aside designation was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,061.57 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This firm fixed-price delivery order, issued on October 31, 2025, with an ultimate completion date of November 3, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Boostrix TDAP vaccine syringes (0.5mL) under a firm fixed-price contract. This delivery order, valued at $13,922.86 with an ultimate completion date of July 21, 2025, was issued without a set-aside designation. The award leverages DMS Pharmaceutical Group's position as a critical supplier within the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,546.24 to DMS Pharmaceutical Group Inc. for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The order was executed on June 18, 2025, with an ultimate completion date of June 20, 2025, and is to be performed in Park Ridge, Illinois. This delivery order was issued without set-aside designation and represents a routine pharmaceutical product fulfillment within DMS Pharmaceutical Group's broader federal supply...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,693.82 to DMS Pharmaceutical Group Inc. for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The contract, effective July 23, 2025, with an ultimate completion date of July 24, 2025, represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026. No set-aside designation was applied to this award. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 27, 2025, by the Defense Logistics Agency for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. The contract carries a ceiling value of $17,048.40 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 28, 2025. No set-aside designation was utilized for this award, and the place of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on June 11, 2025, for Boostrix TDAP vaccine syringes in 0.5ml units. The contract is valued at $1,136.56 and carries a firm fixed-price structure with an ultimate completion date of June 12, 2025. This delivery order was issued without a set-aside designation, and performance will take place at the...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $21,878.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. The contract, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, carries no set-aside designation. DMS Pharmaceutical Group will perform this work at its Park Ridge facility and deliver the...
- The Defense Logistics Agency awarded a delivery order valued at $1,064.40 to DMS Pharmaceutical Group Inc. for Boostrix TDAP vaccine in syringe form (0.5ML) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $48.5K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This firm fixed-price delivery order was awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, and carries no set-aside designation. The contract will be performed in Park Ridge, Illinois, where the vendor...
- SPE2DR25D9311Indefinite Delivery Contract
- SPE2DR25D9311-SPE2DR26FSBE8Delivery Order
The Defense Logistics Agency awarded a $8,486.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Boostrix TDAP vaccine in 0.5ml syringe format. The delivery order, issued on January 6, 2026, with an ultimate completion date of January 7, 2026, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order represents one of numerous purchases issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical sourcing for Department of Defense healthcare operations. DMS Pharmaceutical Group serves as a critical regional prime vendor contractor under the PPV-G GEN V program, which authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products including vaccines, prescription medications, biologics, and medical consumables to support military healthcare facilities worldwide. The contractor's single-award Indefinite Delivery Contract, designated SPE2DR and valued at $499,999,999, extends through December 31, 2036, positioning DMS Pharmaceutical Group as a key supplier within the federal military medical supply chain. The company's established performance across diverse product categories and delivery orders demonstrates its operational capability to fulfill the specialized pharmaceutical requirements of Department of Defense healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 1/5/26 |